CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Fish Oildietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04360239
NCT04360239N/ACompleted

Stopping Fish Oil Supplementation Prior to Total Hip Replacement a Randomized Clinical Trial

Jeffrey L Stimac MD·interventional·Posted Apr 24, 2020·Updated Oct 26, 2024

In Brief

A clinical study evaluating Fish Oil for Total Hip Arthroplasty. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if continuing fish oil supplementation leads to higher blood loss in patients undergoing total hip arthroplasty (THA). Another purpose is to determine if patients on fish oil have less pain after THA. Fish oil (Omega-3 fatty acid) is commonly used by patients as a natural anti-inflammatory to decrease joint pain from arthritis. Supplements, including fish oil, are typically stopped 1-2 weeks prior to surgery as there is an increased risk of perioperative bleeding. However, there are current methods in joint replacement surgery that decrease the risk of perioperative bleeding. With the risk of excessive bleeding being minimized, fish oil may not need to be stopped prior to surgery and could be continued immediately after surgery. The anti-inflammatory effect of fish oil may also help decrease pain after surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 24, 2020
Enrollment StartJun 1, 2020
Primary CompletionMar 22, 2022
Study CompletionJul 10, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.2 years ago

Interventions

Fish Oildietary

Fish-oil formulation of two capsules twice daily (3000 mg of EPA and DHA).